Slight constipation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Japanese male and female ages 20-64 years old (inclusive) (2)Subjects with tendency for constipation at 3 to 5 times of defecation per week (3)Subjects who take 3 meals per day regularly (4)Willing and able to provide signed written informed consent
Exclusion criteria
Exclusion criteria: (1)Subjects with severe hepatic, renal, cardiac, pulmonary, gastrointestinal, hematologic, endocrine and metabolic diseases / disorders (2)Subjects who suffer from diseases/ disorders with continuous medical treatment or with medical history of severe diseases/ disorders needed medical treatment (3)Subjects who suffer from diseases/ disorders that affects the study and are receiving medical treatment from medical institution or have surgical history of digestive system ( except appendectomy) (4)Subjects who suffer from diseases/ disorders that affects bowel movement such as irritable bowel syndrome or ulcerative colitis etc or have medical history of above-mentioned diseases/ disorders (5)Subjects with history of sensitivity to the ingredients (6)Pregnant, lactating women or willing to be pregnancy during the study (7)Subjects who take any kind of medicine ( laxative, intestinal drug etc) that possibly affect bowel movement (8)Subjects who take supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) regularly that possibly affect bowel movement (9)Subjects who have a habit of eating lactic fermenting beverage or food or Lactobacillus preparation that contain many lactobacillus, food fortified with dietary fiber and/or oligosaccharide 3 and more times per week (10)Any candidate considered to be unsuitable for enrollment based on his/her answers of life style questionnaire (11)Subjects who had participated in other clinical trials including drug and food within 1 month. (12)Any candidate considered to be unsuitable for enrollment in the opinion of the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defecation frequency, defecation days(After intervention 11-12 weeks after) | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of defection, fecal condition(form, color, smell, feeling after defecation) | — |
Countries
Japan
Contacts
CROee Inc. Evidence Division